Commentary on Chalmers et al. (2016): A thoughtful integration of routine data sources and primary research findings. by Buykx, P.
This is an author produced version of Commentary on Chalmers et al. (2016): A thoughtful
integration of routine data sources and primary research findings..
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/113644/
Article:
Buykx, P. orcid.org/0000-0003-4788-4002 (2016) Commentary on Chalmers et al. (2016): 
A thoughtful integration of routine data sources and primary research findings. Addiction, 
111 (11). pp. 2050-2051. ISSN 0965-2140 
https://doi.org/10.1111/add.13548
promoting access to
White Rose research papers
eprints@whiterose.ac.uk
http://eprints.whiterose.ac.uk/
Commentary on Chalmers et al (2016) Estimating met demand for alcohol and other drug 
treatment in Australia: a thoughtful integration of routine data sources and primary research 
findings 
Abstract 
Taking a broad health system perspective, Chalmers et al have developed a useful blueprint for 
combining data sources to estimate the number of individuals receiving alcohol and other drug 
treatment. The work of Chalmers et al highlights the importance of key datasets to health service 
system planning and is a powerful argument for the continued funding of such resources. To 
maximise the usefulness of their the Chalmers method as a first step inresults for modelling unmet 
demand, future work could also consider socio-demographic and clinical subgroups. 
 
:Ž ?ƐƐƵŐŐĞƐƚŝŽŶ 
 
Routinely collected data sources are essential for health service system planning, enabling 
estimations of both met and unmet demand. Future modelling of unmet demand could consider 
socio-demographic and clinical subgroups as well as regional level data 
Commentary 
Chalmers et al (1) address the challenge of estimating the number of unique individuals receiving 
alcohol and other drug treatment (AOD) in Australia in a single year. As in many countries, the 
Australian AOD treatment system is comprised of multiple inter-related sub-systems with varying 
ŵĞĐŚĂŶŝƐŵƐĨŽƌƌĞĐŽƌĚŝŶŐ ?ƚƌĞĂƚŵĞŶƚĞŶĐŽƵŶƚĞƌƐ ?ĞƉŝƐŽĚĞƐŽĨĐĂƌĞ ?ĂŶĚĐŽŶƐƵůƚĂƚŝŽŶƐ ?. Further, an 
individual may interact with multiple subsystems on multiple occasions. The complexity of 
relationships between specialist treatment ĂŶĚŽƚŚĞƌƐĞƌǀŝĐĞƐǁŝƚŚŝŶĂƚƌĞĂƚŵĞŶƚ ?ƐǇƐƚĞŵ ?ŝƐ
recognised in the conceptual model of Babor and colleagues.(2) However, even where well-
developed treatment utilization monitoring protocols are in place, such as in Belgium, they do not 
necessarily include the full range of AOD specialist and non-specialist services.(3) 
The authors build upon their previously published treatment provider map (4) to identify potential 
data sources, as well as additional primary research evidence to inform both the conversion of 
episodes to unique people within datasets and to avoid double counting of individuals across 
datasets. A methodological strength of the Chalmers et al paper is the clarity with which the relevant 
datasets and conversion factors are described, as well as the step by step process of estimation. 
While available data sources will differ between countries, the consideration given here to what 
evidence can be used to underpin assumptions about multiple treatment contacts within the one 
sub-system or use of several sub-systems will be instructive for similar estimation efforts elsewhere. 
For example, the estimated proportion of entrants to treatment who had also utilized hospital or 
other outpatient services was available from a study of patient pathways in Australian alcohol and 
drug treatment.(5, 6) Similar data are potentially available in other countries, either through studies 
involving in treatment populations such as for the TREAT-project,(7) or through general population 
surveys such as the US National Epidemiologic Survey on Alcohol and Related Conditions.(8) 
Understanding the extent of met demand is important not only for accurately estimating current 
service provision, but is also a crucial input for estimating the extent of unmet treatment demand.(9, 
10) The authors rightly arŐƵĞĞƐƚŝŵĂƚŝŽŶŽĨŵĞƚĚĞŵĂŶĚŝƐĂ ?ĨƵŶĚĂŵĞŶƚĂůƉŝĞĐĞŽĨƚŚĞƉůĂŶŶŝŶŐ
ƉƵǌǌůĞ ?ďĞĐĂƵƐĞǁŚĞŶconsidered in conjunction with estimates of the prevalence of dependence on 
alcohol and other drugs, it provides insight into the size of the potentially in-need population who 
are not currently accessing any form of treatment. The authors indicate such work requires 
sophisticated modelling techniques beyond the scope of the study. Should the authors extend their 
work in that direction, there are a number of additional factors which such modelling of treatment 
utilisation in relation to underlying prevalence of dependence could usefully take into account. 
These include the nature (e.g. alcohol, opioids) and severity of dependence, complex needs (e.g. 
polysubstance use, mental health problems), and the age and gender of individuals needing and 
using treatment, all of which may influence the both the likelihood of treatment being sought and 
type of treatment required.(11-14) Consideration of lower-level geographies would also be useful, as 
there are likely to be regional differences in both substance dependence and available services in 
many countries.(9, 15, 16) Sub-national estimates of the distribution of met demand are therefore 
required to ascertain the scale geographic disparity in treatment access rates. 
This paper highlights the value of routinely collected data sources in health service system 
monitoring and planning. While the development of a method for estimating met need was clearly a 
substantial stand-alone project, updating these for ongoing monitoring of the quantum of treatment 
provision an annual basis should be a relatively straightforward undertaking as new yearly data 
become available. However, as the recent disinvestment in the BEACH study (17, 18) makes 
abundantly clear, ongoing funding for key datasets cannot be assumed. There is therefore an onus 
upon end users (including researchers) to continue to engage with relevant funders to argue for the 
preservation of key datasets, drawing attention to how they can be used singly or in combination to 
inform health service system planning. 
 
Dr Penny Buykx 
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